Galantamine in Alzheimer's disease.
Galantamine is a cholinesterase inhibitor with a dual mechanism of action. It is a reversible inhibitor of acetylcholine esterase and enhances the intrinsic action of acetylcholine on nicotinic receptors, leading to increased cholinergic neurotransmission in the CNS. Galantamine has a large volume c...
Principais autores: | Razay, G, Wilcock, G |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2008
|
Registros relacionados
-
The beneficial effects of galantamine on caregiver time in Alzheimer's disease
por: Sano, M, et al.
Publicado em: (2003) -
The effects of galantamine treatment on caregiver time in Alzheimer's disease.
por: Sano, M, et al.
Publicado em: (2003) -
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
por: Wilcock, G, et al.
Publicado em: (2000) -
Hyperinsulinaemia and Alzheimer's disease.
por: Razay, G, et al.
Publicado em: (1994) -
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
por: Wilcock, G, et al.
Publicado em: (2003)